Jason Garnett, CEO and Director, acquired 1,666,667 Common Shares on a direct ownership basis at a price of $0.150 through a prospectus or prospectus exempt offering on November 18th, 2019. This represents a $250,000 investment into the company's shares and an account share holdings change of greater than 100%.
Experion Holdings is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Experion Holdings Ltd., formerly Viridium Pacific Group Ltd, is a Canada-based company that is engaged in the medical cannabis sector. Viridium Pacific Group Ltd owns a controlling interest in Experion Biotechnologies Inc (Experion). Experion Biotechnologies Inc is a science-led company that conducts business in the cannabis production industry. Experion Biotechnologies Inc holds a license to produce cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR), granted by Health Canada. Experion Biotechnologies Inc's objective is the: production of whole plant, starter material; production of dried marijuana flowers, as well as the distribution of its production, including the wholesale distribution of its starter material to licensed growers and marijuana flower product for wholesale and retail distribution across Canada.
No Comments